OMB Approval
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response: 14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
MEDPLUS CORPORATION
---------------------------------------------------
Name of Issuer
COMMON STOCK, PAR VALUE $.001
---------------------------------------------------
Title of Class of Securities
584956106
---------------------------------------------------
CUSIP No.
WILLIAM C. MEIER
2350 Airport Freeway, Suite 660
Bedford, Texas 76022
817-283-9528
----------------------------------------------------
Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications
August 19, 1997
----------------------------------------------------
Date of Event Which Requires Filing of this Statement
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4),
check the following box: ______
<PAGE>
SCHEDULE 13D
CUSIP No. 090646-10-0
Page 2 of 3 Pages
1. Name of Reporting Person
WILLIAM C. MEIER
2. Check the appropriate box if a member of a Group:
(A) X - WCM Investments, Inc.
(B)
3. SEC USE ONLY
4. SOURCE OF FUNDS
PF
5. Check box if disclosure of legal proceedings is required
pursuant to items 2(d) or 2 (e):
Not applicable.
6. Citizenship or place of organization:
USA
7. Sole Voting Power:
Yes - 1,000,000 shares
8. Shared Voting Power:
No
9. Sole Dispositive Power:
Yes - 1,000,000 shares
10. Shared Dispositive Power:
No
<PAGE>
Page 3 of 3 Pages
11. Aggregate Amount Beneficially owned by each reporting
person:
1,000,000 shares
12. Check box if the aggregate amount in row (11) excludes
certain shares:
Not applicable.
13. Percent of Class represented by amount in Row (11).
13.63%
14. Type of Reporting Person
IN
ITEM 1. SECURITY AND ISSUER
This statement relates to the common stock, $.001 par value per share (the
"common stock") of Medplus Corporation, a Delaware corporation (the
"Company"). The Company's principal executive offices are located at 8 South
Nevada Steet, Suite 204, Colorado Springs, Colorado 80903.
ITEM 2. IDENTITY AND BACKGROUND
The record owner of the common stock is WCM Investments, Inc. whose sole
shareholder is William C. Meier, thus the following information refers
solely to him. Mr. Meier (the "Reporting Invididual") is a practicing
attorney and businessman located at 2350 Airport Freeway, Suite 660,
Bedford, Texas 76022. During the last five years, the Reporting Individual
has not been convicted in a criminal proceeding (excluding traffic
violatons or similar misdemeanors) nor been a party to a civil proceeding
of a judicial or administrative body of competent jurisdiction resulting
in him being subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to
federal or state securities laws or finding any violations with respect
to such laws. The Reporting Individual is a United States citizen.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
No monetary compensation was paid to the Company by the Reporting Individual
for the shares. The shares were issued to the Reporting Individual by the
Company as compensation to the Reporting Individual for consulting and
finder services performed for the Company.
ITEM 4. PURPOSE OF TRANSACTION
The purpose of the acquisition of the common stock is to make a speculative
investment and in order to provide consulting services to the Company
relating to future acquisitions of target companies beneficial to the
shareholders of the Company. Although the Reporting Person has devoted
substantial effort in exploring potential acquisitions which may have
potential relevance to matters referred to in paragraphs (a) through (d)
of Item 4. of Schedule 13D, unresolved conditions precedent remain and it
is unclear at this time whether there will be any successful closing of
any acqusitions.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
According to information supplied to the Reporting Individual by the
Company, the number of shares of common stock outstanding as of
August 19, 1997 is 7,334,923. Accordingly, to the Reporting Individual
is the beneficial owner of 1,000,000 shares, which is 13.63%
of the outstanding common stock calculated in accordance with Rule
13D-3(d)(i). The reporting individual will have sole voting and
dispositive power with respect to these shares.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS
WITH RESPECT TO SECURITIES OF THE ISSUER.
Other than the purchase of the shares, there are no other contracts,
arrangements, understandings or relationships (legal or otherwise)
between the Reporting Individual and any other person with respect
to any securities of the Company, including but not limited to,
transfer or voting of any of the securities of the Company, finders
fees, joint ventures, loan or option arrangements, puts or calls,
guarantee of profits, division of profits and loss, or the withholding
of proxies.
ITEMS 7. MATERIAL TO BE FILED AS EXHIBITS.
None.
Dated: September 19, 1997 /S/ WILLIAM C. MEIER
------------------------
WILLIAM C. MEIER